Research / mechanism + evidence
How NAD+ works, and what the human trials measured
The redox coenzyme, the three enzyme families that consume it, and the precursor trials - read on a tiered console that keeps established findings apart from preliminary ones.
In plain English
NAD+ does two jobs in a cell. First, it is a shuttle in redox chemistry (the chemistry that moves electrons to release energy from food) - it picks up electrons to become NADH, then drops them off to help make energy [5]. Second, three families of enzymes physically use up NAD+ as a raw material when they do their work: sirtuins, PARPs and CD38. Because they all draw from the same pool, they effectively compete for NAD+ [9]. As we age, the pool shrinks - partly because CD38 ramps up [2]. This page walks through that mechanism and then through what the human NAD+ trials actually found, marking each result by how strong the evidence is.
The redox coenzyme: NAD+ and NADH
NAD+ (nicotinamide adenine dinucleotide) is a dinucleotide - two nucleotides joined by a two-phosphate bridge, one carrying a nicotinamide ring and one an adenine ring, molecular weight 663.43 Da [5]. The "+" denotes the oxidized form; NADH is the reduced form. The molecule cycles between the two states constantly, accepting electrons during the breakdown of glucose and fat and donating them in the mitochondrial electron-transport chain to drive ATP synthesis [5]. This redox role is why every living cell makes and maintains NAD+ from scratch - from tryptophan, from nicotinic acid, and chiefly through the salvage pathway that recycles nicotinamide [5][13].
Sirtuins, PARPs and CD38
Beyond redox, NAD+ is a consumed substrate for three signaling-enzyme families, and the sirtuins-PARP-CD38 axis is the mechanistic core of the aging story [5]. Sirtuins (SIRT1-SIRT7) are NAD+-dependent deacylases that regulate metabolism, stress resistance, DNA repair and, in model organisms, lifespan; their activity is rate-limited by how much intracellular NAD+ is available [7]. PARP1 (poly(ADP-ribose) polymerase 1) is a DNA-repair enzyme that consumes large amounts of NAD+ when activated by DNA damage - and because PARP1 and SIRT1 draw on the same pool, heavy PARP1 activation can suppress SIRT1 by substrate competition [9]. CD38 is an NAD-consuming ectoenzyme whose activity rises with age and inflammation; in mice, deleting CD38 preserves NAD+ levels and SIRT3 activity and protects mitochondrial function with age [2]. A linked mechanism: senescent cells accumulating with age secrete inflammatory factors that activate CD38-positive macrophages, and clearing those senescent cells partially restored tissue NAD+ in mice [8].
What a NAD+ precursor is
A NAD+ precursor is a building block the body converts into NAD+ - the common oral ones are NMN and NR. The dominant route in mammals is the salvage pathway, which recycles nicotinamide back into NAD+ through NMN, with the enzyme NAMPT as the rate-limiting step [13]. Nicotinamide riboside takes a partly separate route: NRK1/NRK2 kinases phosphorylate it to NMN, a Preiss-Handler-independent shortcut whose structural basis was worked out from crystal structures of human Nrk1 [15][13]. NAMPT itself is a candidate target in neurodegenerative-disease biology, with high expression in the hippocampus linked to neural stem-cell NAD+ synthesis [14]. The practical consequence is the one this site keeps returning to: you raise NAD+ by feeding the pathway a precursor, not by swallowing the large, poorly-absorbed NAD+ molecule itself.
Muscle, mitochondria and the NAD+ pool
The link between low NAD+ and declining muscle is one of the better-supported human observations. In muscle biopsies from 119 older men across three populations, sarcopenia tracked with a transcriptional signature of mitochondrial dysfunction, fewer mitochondria and low NAD+ through perturbed NAD+ biosynthesis and salvage [11]. The causal direction is supported in cells: knocking down NAMPT in mouse myoblasts and skeletal muscle lowered NAD+ and impaired maximal respiratory capacity, and adding nicotinamide riboside restored NAD+ and increased respiration [12]. On the human-trial side, the 250 mg/day NMN study in prediabetic postmenopausal women is the cleanest functional result: improved muscle insulin sensitivity and remodeled insulin signaling, with no change in body composition [1].
The honest gap: blood NAD+ up, hard outcomes unproven
Raising blood NAD+ is established; translating it into clinical benefit is not. The most-cited 2025 narrative review of NAD+ precursor supplementation in human aging concluded that trials have shown limited efficacy for hard clinical endpoints, that age-related NAD+ decline has been confirmed only in a limited number of human studies, and that data on tissue-specific NAD+ dynamics remain sparse - the authors call for more clinical study rather than reliance on rodent extrapolation [16]. A separate caution belongs here: because NAD+ supports proliferating cells, boosting it has dual, context-dependent roles in cancer biology, and the literature advises caution in cancer populations [16]. None of this is a recommendation; it is the boundary of what the studies support.
Does NAD cause weight gain?
The studies do not show NAD+ causing weight gain. In mice, long-term NMN suppressed age-associated weight gain, and human trials such as the 250 mg/day NMN study report no change in body composition [1]. The evidence points away from weight gain, not toward it.
Does NAD help with weight loss?
The dealt studies do not establish weight loss as an NAD+ outcome. Some trials report improved muscle insulin sensitivity at higher precursor doses [1], but that is a metabolic marker, not weight loss, and human NMN trials reported no body-composition change [1][3].
Does NAD make you look younger?
No trial demonstrates a cosmetic younger appearance from NAD+. Mechanistic studies link low NAD+ to aging biology - declining sirtuin activity and mitochondrial dysfunction [6][7] - but human anti-aging outcomes remain preliminary, and the 2025 Nature Metabolism review concludes hard clinical benefits are not yet established [16].
Does NAD help with fertility?
Fertility is outside the evidence base dealt here. Reviews caution that the strongest NAD+ data are mechanistic or from rodents and that human endpoints remain unproven [16]. This site does not make a fertility claim, because the cited studies do not support one.
What is the best time to take NAD, morning or night?
NAMPT (the salvage-pathway enzyme that makes NAD+) and NAD+ itself follow a CLOCK-SIRT1-driven circadian rhythm, so NAD+ levels oscillate over 24 hours [10]. But no trial establishes a best time of day to take a precursor, and this page reports the biology rather than recommending a schedule.